Axon Enterprise (NASDAQ:AXON) Trading Down 7.4% After Analyst Downgrade

Key Points

• Shares fell 7.4% intraday to about $362 after TD Cowen cut its price target from $950 to $825; trading volume was ~350,025 shares (down ~65% vs. average) and the stock sits well below its 50‑ and 200‑day moving averages near a 52‑week low.
• Analysts remain broadly positive with a “Moderate Buy” consensus (16 Buys, 3 Holds) and an average target of $755.88, and Axon recently beat estimates (EPS $2.15 vs. $1.60) with revenue up 38.5% year‑over‑year.
• Insiders sold ~13,855 shares (~$7.11M) in the past 90 days (insider ownership 4.40%), while the company is rolling out three new AI tools designed to support recurring software and service growth amid near‑term legal and market headwinds.

Shares of Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) were down 7.4% during mid-day trading on Thursday after TD Cowen lowered their price target on the stock from $950.00 to $825.00. TD Cowen currently has a buy rating on the stock. Axon Enterprise traded as low as $362.30 and last traded at $362.4980. Approximately 350,025 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 997,971 shares. The stock had previously closed at $391.53.

AXON has been the topic of a number of other reports. Craig Hallum restated a "buy" rating and issued a $820.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 25th. Northcoast Research raised Axon Enterprise from a "neutral" rating to a "buy" rating and set a $742.00 target price on the stock in a report on Tuesday, January 6th. Barclays decreased their target price on Axon Enterprise from $702.00 to $682.00 and set an "overweight" rating on the stock in a report on Wednesday, February 25th. Citigroup restated a "buy" rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Robert W. Baird set a $800.00 price target on Axon Enterprise in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $755.88.

Insiders Place Their Bets

In other Axon Enterprise news, Director Erika Nardini sold 198 shares of the company's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the sale, the director owned 1,946 shares in the company, valued at $985,804.68. This represents a 9.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the sale, the chief accounting officer owned 12,240 shares of the company's stock, valued at approximately $7,019,028. The trade was a 10.92% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 13,855 shares of company stock valued at $7,109,828. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon unveiled three AI tools (Axon Vision, expanded Axon Assistant and Axon 911) aimed at stitching live video, 911 and field data into real‑time intelligence — a product roadmap that supports recurring software and service growth. Axon Tackles Public Safety's Data Overload With Three New AI Tools
• Positive Sentiment: Several analysts issued bullish notes or maintained buy ratings during Axon Week, helping shares rebound and driving short‑term positive sentiment. Axon Enterprise stock rises 4% on analyst optimism
• Neutral Sentiment: Major firms trimmed price targets (Goldman Sachs cut to $625; TD Cowen to $825) but kept buy ratings — signaling confidence in the long‑term thesis while moderating near‑term upside assumptions. Benzinga PT coverage Goldman PT cut report
• Negative Sentiment: Shares plunged ~10% earlier in the week after headlines raised new legal risk around Axon’s HQ and several price‑target cuts; that selloff and subsequent 52‑week low pressure remain near‑term negatives. Axon Stock Plunged on Tuesday. Is This a Buying Opportunity? Why Axon (AXON) Shares Are Trading Lower Today
• Negative Sentiment: Broader market headwinds (geopolitical tensions and tech‑led Nasdaq weakness) compounded selling pressure on Axon, contributing to intraday volatility and the stock hitting a 52‑week low. Why Axon Shares Are Sliding Tuesday?

Institutional Investors Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently bought and sold shares of the business. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the fourth quarter valued at about $28,000. Stone House Investment Management LLC bought a new stake in Axon Enterprise during the third quarter valued at about $29,000. New Millennium Group LLC bought a new stake in Axon Enterprise during the third quarter valued at about $29,000. Sound Income Strategies LLC raised its holdings in Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company's stock valued at $30,000 after acquiring an additional 44 shares during the period. Finally, Camelot Portfolios LLC bought a new stake in Axon Enterprise during the fourth quarter valued at about $30,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Down 7.3%

The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The stock has a fifty day simple moving average of $470.33 and a 200 day simple moving average of $571.34. The firm has a market capitalization of $29.19 billion, a P/E ratio of 238.64, a PEG ratio of 8.81 and a beta of 1.61.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating analysts' consensus estimates of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million for the quarter, compared to analysts' expectations of $755.29 million. During the same period last year, the firm earned $2.08 earnings per share. The business's quarterly revenue was up 38.5% on a year-over-year basis. As a group, research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.